In June 2017, the O’Neill Institute established an HIV Prevention Project to understand what is working in HIV prevention, identify issues and opportunities for progress, and describe future directions for HIV prevention. The goal of the project is to engage with federal, state, and local policy and program staff, people living with HIV, researchers and others to explore these issues and describe a vision for future progress. This project is supported by a grant from Gilead Sciences.
Quick Take on HIV Prevention in the United States
Released in January 2019, this Quick Take document provides an overview of the HIV epidemic in the United States and describes the range of tools and approaches used to prevent HIV infection, including HIV testing and linkage to care, treatment as prevention, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), and syringe and harm reduction services. The document also discusses the need for continued support for and new investment in HIV prevention.
Federal Investments Are Saving Lives and Strengthening Communities
At a time when many policy makers are asking fundamental questions about the impact of public investments on various programs, this issue brief examines the dynamic nature of the HIV epidemic in the United States to assess what our country has accomplished, where things stand, and where continued federal leadership and funding are needed to keep reducing the size and scope of the HIV epidemic.
HIV Prevention in the United States: Federal Investments are Saving Lives and Strengthening Communities
Jeffrey S. Crowley and Sean E. Bland
Thematic Area: Infectious Diseases